Earnings History For Amneal Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Earnings history for amneal pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Earnings History For Amneal Pharmaceuticals Today - Breaking & Trending Today

Amneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on Friday

Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, May 3rd. Analysts expect the company to announce earnings of $0.08 per share for the quarter. Amneal Pharmaceuticals has set its FY 2024 guidance at 0.530-0.630 EPS.Parties that are interested in participating in […] ....

Piper Sandler , Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Earnings History For Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Goldman Sachs Group , Amneal Pharmaceuticals Trading , Get Free Report , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) issued its quarterly earnings results on Friday. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01, Yahoo Finance reports. Amneal Pharmaceuticals had a positive return on equity of 76.11% and a negative net margin of 5.88%. The firm had revenue […] ....

United States , Amneal Pharmaceuticals Stock , Institutional Trading Of Amneal Pharmaceuticals , Earnings History For Amneal Pharmaceuticals , Amneal Pharmaceuticals , Goldman Sachs Group , Amneal Pharmaceuticals Inc , Pricet Rowe Associates Inc , American Century Companies Inc , News Ratings For Amneal Pharmaceuticals Daily , Squarepoint Ops , Get Rating , Yahoo Finance , Century Companies , Gate Manager , Amneal Pharmaceuticals Daily , Nyse Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Releases Earnings Results, Misses Estimates By $0.01 EPS

Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) released its earnings results on Wednesday. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.01), MarketWatch Earnings reports. Amneal Pharmaceuticals had a return on equity of 61.08% and a net margin of 0.68%. The company had revenue of $497.30 […] ....

Amneal Pharmaceuticals , Morgan Stanley , Geode Capital Management , Zacks Investment Research , Norges Bank , Deutsche Bank , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Get Rating , Earnings History For Amneal Pharmaceuticals , Millennium Management , Get Rating , Marketwatch Earnings , Investment Research , Capital Management , Nyse Amrx ,